Summary & Overview
HCPCS G6031: Benzodiazepines
HCPCS Level II code G6031 denotes benzodiazepines, a widely used class of psychotropic medications relevant to outpatient prescribing and pharmacy dispensing nationwide. This code matters because benzodiazepines are commonly prescribed across care settings and are subject to utilization controls, safety monitoring, and payer-specific coverage policies. National attention to appropriate use, dependency risk, and opioid-benzodiazepine co-prescribing makes clarity on billing and coverage important for providers, payers, and pharmacy benefit managers.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage considerations and payer presence, clinical context for benzodiazepine use, and how the code maps to outpatient medication dispensing workflows. The publication summarizes benchmarks where available, highlights relevant policy points affecting national billing and coverage, and situates G6031 within routine ambulatory pharmacy and outpatient clinic service lines.
The content is intended to help coding, billing, and compliance teams understand the operational and policy dimensions of HCPCS Level II code G6031 for benzodiazepines at a national level.
Billing Code Overview
HCPCS Level II code G6031 represents Benzodiazepines, a class of medications commonly used for anxiety, insomnia, seizure disorders, and muscle relaxation. The service type for this code is medication dispensing or drug therapy related to benzodiazepine provision. The typical site of service is ambulatory pharmacy or outpatient clinic where benzodiazepine medications are prescribed, dispensed, or administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult receiving a monitored medication management visit in an outpatient behavioral health clinic or primary care setting where benzodiazepine therapy is being prescribed, reviewed, or reconciled. The patient may present with generalized anxiety disorder, panic disorder, insomnia, or muscle spasm and reports inadequate symptom control or adverse effects. The clinical workflow includes medication history review, assessment of current symptoms and functional status, evaluation of risk factors for misuse (including substance use history and concurrent opioid therapy), discussion of risks and benefits, documentation of informed consent when applicable, and adjustment of dose or plan for tapering. The service is frequently billed when pharmacy-related services for benzodiazepine dispensing, testing, or monitoring are provided as part of a clinic visit, inpatient psychiatric consult, or community mental health program. Typical sites of service include outpatient behavioral health clinics, primary care offices, hospital inpatient psychiatric units, and community mental health centers. Common scenario modifiers include the technical component TC when only the technical aspects of a diagnostic or laboratory test related to benzodiazepine monitoring (e.g., urine drug screen processing) are billed separately from the professional interpretation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
TC | Technical component |